The diagnosis and treatment of infection in the burn patient.
D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis / Q000628:therapy; D001706:Biopsy; D002056:Burns / Q000150:complications* / Q000276:immunology; D003646:Debridement; D006801:Humans; D008272:Mafenide / Q000627:therapeutic use; D009181:Mycoses / Q000175:diagnosis / Q000628:therapy; D009504:Neutrophils / Q000276:immunology; D011014:Pneumonia / Q000175:diagnosis; D012306:Risk; D012835:Silver Nitrate / Q000627:therapeutic use; D012837:Silver Sulfadiazine / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D014774:Virulence; D014777:Virus Diseases / Q000175:diagnosis / Q000628:therapy; D014946:Wound Infection / Q000175:diagnosis* / Q000628:therapy*
D000935:Antifungal Agents; D008272:Mafenide; D012835:Silver Nitrate; D012837:Silver Sulfadiazine